PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 30306750-13 2018 CONCLUSIONS: EDN is a useful relatively non-invasive biomarker for predicting responses to montelukast and budesonide treatment of preschool children with beta2-agonist responsive recurrent wheeze and multiple-trigger wheeze (Trial registry at UMIN Clinical Trials Registry, UMIN000008335). Budesonide 107-117 potassium calcium-activated channel subfamily M regulatory beta subunit 2 Homo sapiens 155-160